Zhu Y - Search Results

1

Metabolic Reprogramming in Cardiovascular Diseases.

Gao J, Zhu Y, Bei Y. Gao J, et al. Among authors: zhu y. J Cardiovasc Transl Res. 2024 Feb;17(1):33-35. doi: 10.1007/s12265-024-10491-0. Epub 2024 Feb 14. J Cardiovasc Transl Res. 2024. PMID: 38356018 No abstract available.

2

Noncoding RNAs in Cardiac Hypertrophy.

Li Y, Liang Y, Zhu Y, Zhang Y, Bei Y. Li Y, et al. Among authors: zhu y. J Cardiovasc Transl Res. 2018 Dec;11(6):439-449. doi: 10.1007/s12265-018-9797-x. Epub 2018 Aug 31. J Cardiovasc Transl Res. 2018. PMID: 30171598 Review.

3

Immunomodulation by Exosomes in Myocardial Infarction.

Pan W, Zhu Y, Meng X, Zhang C, Yang Y, Bei Y. Pan W, et al. Among authors: zhu y. J Cardiovasc Transl Res. 2019 Feb;12(1):28-36. doi: 10.1007/s12265-018-9836-7. Epub 2018 Oct 29. J Cardiovasc Transl Res. 2019. PMID: 30374796 Review.

4

miR-486 attenuates cardiac ischemia/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection.

Bei Y, Lu D, Bär C, Chatterjee S, Costa A, Riedel I, Mooren FC, Zhu Y, Huang Z, Wei M, Hu M, Liu S, Yu P, Wang K, Thum T, Xiao J. Bei Y, et al. Among authors: zhu y. Mol Ther. 2022 Apr 6;30(4):1675-1691. doi: 10.1016/j.ymthe.2022.01.031. Epub 2022 Jan 22. Mol Ther. 2022. PMID: 35077859 Free PMC article.

5

Lymphangiogenesis contributes to exercise-induced physiological cardiac growth.

Bei Y, Huang Z, Feng X, Li L, Wei M, Zhu Y, Liu S, Chen C, Yin M, Jiang H, Xiao J. Bei Y, et al. Among authors: zhu y. J Sport Health Sci. 2022 Jul;11(4):466-478. doi: 10.1016/j.jshs.2022.02.005. Epub 2022 Feb 23. J Sport Health Sci. 2022. PMID: 35218948 Free PMC article.

6

ALDH2: Essential Mediator for the Remote Ischemic Conditioning Strategy to Reduce Myocardial Ischemia/Reperfusion Injury.

Zhu Y, Jiao Z, Bei Y. Zhu Y, et al. J Cardiovasc Transl Res. 2024 Feb;17(1):167-168. doi: 10.1007/s12265-023-10362-0. Epub 2023 Mar 20. J Cardiovasc Transl Res. 2024. PMID: 36941397 No abstract available.

7

Dkk1: a Putative Protector Against Vascular Calcification.

Zhu Y, Jiao Z, Bei Y. Zhu Y, et al. J Cardiovasc Transl Res. 2023 Apr;16(2):267-268. doi: 10.1007/s12265-022-10292-3. Epub 2023 Mar 21. J Cardiovasc Transl Res. 2023. PMID: 36943616 No abstract available.

8

Danlou Tablet Protects Against Cardiac Remodeling and Dysfunction after Myocardial Ischemia/Reperfusion Injury through Activating AKT/FoxO3a Pathway.

Li L, Qi W, Zhu Y, Yin M, Chen C, Wei M, Huang Z, Su Z, Jiang J, Zhang M, Bei Y. Li L, et al. Among authors: zhu y. J Cardiovasc Transl Res. 2023 Aug;16(4):803-815. doi: 10.1007/s12265-023-10365-x. Epub 2023 Apr 10. J Cardiovasc Transl Res. 2023. PMID: 37036598

9

HIPK1 Inhibition Protects against Pathological Cardiac Hypertrophy by Inhibiting the CREB-C/EBPβ Axis.

Bei Y, Zhu Y, Wei M, Yin M, Li L, Chen C, Huang Z, Liang X, Gao J, Yao J, van der Kraak PH, Vink A, Lei Z, Dai Y, Chen H, Liang Y, Sluijter JP, Xiao J. Bei Y, et al. Among authors: zhu y. Adv Sci (Weinh). 2023 Jun;10(18):e2300585. doi: 10.1002/advs.202300585. Epub 2023 Apr 26. Adv Sci (Weinh). 2023. PMID: 37098980 Free PMC article.

10

Danlou Tablet Protects Against Myocardial Infarction Through Promoting eNOS-Dependent Endothelial Protection and Angiogenesis.

Zhu Y, Chai Y, Su Z, Qi W, Yin M, Li L, Wei M, Ge J, Wang H, Jiao Z, Bei Y. Zhu Y, et al. J Cardiovasc Transl Res. 2024 Apr;17(2):403-416. doi: 10.1007/s12265-023-10437-y. Epub 2023 Oct 2. J Cardiovasc Transl Res. 2024. PMID: 37784003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50,581 results

Search Page